🇺🇸 FDA
Patent

US 8232373

Immunogenic peptide composition for the prevention and treatment of alzheimer's disease

granted A61KA61K39/00A61P

Quick answer

US patent 8232373 (Immunogenic peptide composition for the prevention and treatment of alzheimer's disease) held by United Biomedical, Inc. expires Mon Jul 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United Biomedical, Inc.
Grant date
Tue Jul 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K39/00, A61P, A61P25/28, A61P37/04